Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Mol Cancer Ther. 2017 Sep 1;16(11):2399–2409. doi: 10.1158/1535-7163.MCT-16-0452

Table 1.

Summary of the rate of apoptosis in KPC cells with/without c-Met knockdown after inhibitor treatment.

c-Met status Treatment group Percentage of Annexin V
positive cells (+/− SEM)
shRNA-Ctrl DMSO 10.59 +/− 0.23
c-Met 22.36 +/− 1.09
Hh 36.47 +/− 0.85
shRNA-c-Met DMSO 69.19 +/− 2.56
c-Met 70.26 +/− 0.98
Hh 71.17 +/− 1.12

Note: Fisher’s test was performed. There is a statistically significant difference (p< 0.0001) between the DMSO treated and Hh inhibitor treated KPC tumor cells transfected with shRNA-Ctrl. There is no statistical difference between treatments of cells transfected with c-Met shRNA. Data are shown as the mean +/− standard error of the mean (SEM)